INTENSIVE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE TREATMENT OF HIGHER-RISK NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY

被引：72
作者：
CAMITTA, B
MAHONEY, D
LEVENTHAL, B
LAUER, SJ
SHUSTER, JJ
ADAIR, S
CIVIN, C
MUNOZ, L
STEUBER, P
STROTHER, D
KAMEN, BA
机构：
[1] MED COLL WISCONSIN,MIDWEST CHILDRENS CANC CTR,DEPT PEDIAT,MILWAUKEE,WI 53226
[2] CHILDRENS HOSP WISCONSIN,MILWAUKEE,WI 53201
[3] WEBSTER CLIN,GREEN BAY,WI
[4] ST VINCENTS HOSP,GREEN BAY,WI
[5] BAYLOR COLL MED,HOUSTON,TX 77030
[6] UNIV TEXAS,SW MED CTR,DALLAS,TX
[7] JOHNS HOPKINS UNIV,CTR ONCOL,BALTIMORE,MD 21205
[8] PEDIAT ONCOL GRP,STAT OFF,GAINESVILLE,FL
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 07期
关键词：
D O I：
10.1200/JCO.1994.12.7.1383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1383 / 1389
页数：7
相关论文
共 29 条
  • [1] HIGH-DOSE METHOTREXATE IMPROVES CLINICAL OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - ST-JUDE TOTAL THERAPY STUDY
    ABROMOWITCH, M
    OCHS, J
    PUI, CH
    KALWINSKY, D
    RIVERA, GK
    FAIRCLOUGH, D
    LOOK, AT
    HUSTU, HO
    MURPHY, SB
    EVANS, WE
    DAHL, GV
    BOWMAN, WP
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05): : 297 - 303
  • [2] SEQUENCE-DEPENDENT, TIME-DEPENDENT AND DOSE-DEPENDENT SYNERGISM OF METHOTREXATE AND 6-MERCAPTOPURINE IN MALIGNANT HUMAN T-LYMPHOBLASTS
    BOKKERINK, JPM
    BAKKER, MAH
    HULSCHER, TW
    DEABREU, RRA
    SCHRETLEN, EDAM
    VANLAARHOVEN, JPRM
    DEBRUYN, CHMM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (20) : 3549 - 3555
  • [3] BUCHANAN GR, 1990, HEMATOL ONCOL CLIN N, V4, P971
  • [4] INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE THERAPY FOR NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    CAMITTA, B
    LEVENTHAL, B
    LAUER, S
    SHUSTER, JJ
    ADAIR, S
    CASPER, J
    CIVIN, C
    GRAHAM, M
    MAHONEY, D
    MUNOZ, L
    KIEFER, G
    KAMEN, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1539 - 1544
  • [5] CASPER J, 1992, BLOOD S, V80, pA65
  • [6] EVANS WE, 1991, SEMIN HEMATOL, V28, P15
  • [7] CLINICAL PHARMACODYNAMICS OF HIGH-DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC-LEUKEMIA - IDENTIFICATION OF A RELATION BETWEEN CONCENTRATION AND EFFECT
    EVANS, WE
    CROM, WR
    ABROMOWITCH, M
    DODGE, R
    LOOK, AT
    BOWMAN, WP
    GEORGE, SL
    PUI, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (08) : 471 - 477
  • [8] MTX CLEARANCE IS MORE IMPORTANT FOR INTERMEDIATE-RISK ALL
    EVANS, WE
    SCHELL, MJ
    PUI, CH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) : 1115 - 1116
  • [9] COMPARISON OF INTERMEDIATE-DOSE METHOTREXATE WITH CRANIAL IRRADIATION FOR THE POST-INDUCTION TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDREN
    FREEMAN, AI
    WEINBERG, V
    BRECHER, ML
    JONES, B
    GLICKSMAN, AS
    SINKS, LF
    WEIL, M
    PLEUSS, H
    HANANIAN, J
    BURGERT, EO
    GILCHRIST, GS
    NECHELES, T
    HARRIS, M
    KUNG, F
    PATTERSON, RB
    MAURER, H
    LEVENTHAL, B
    CHEVALIER, L
    FORMAN, E
    HOLLAND, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (09) : 477 - 484
  • [10] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY
    FREI, E
    CANELLOS, GP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 585 - 594
123